Skip to main content
CMEducation Resources ScrollCall
  • menu
  • menu
  • person
  • Search
  • Specialty
  • Cardiology chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • Diabetes chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • Specialty Program
  • Hypothyroidism chevron_right
  • Specialty Program
  • Parkinson's Diseasechevron_right
  • Specialty
  • Cancer chevron_right

  • Specialty Program
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Pain Management chevron_right
  • Specialty
  • Primary Care chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Parkinson's Diseasechevron_right
  • Glycemic Regulation chevron_right
  • Specialty
  • Dermatology chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Specialty
  • Biologicschevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Biosimilars for RA chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Fabry Disease chevron_right
  • Specialty
  • MAC Lung Disease chevron_right

  • Specialty Program
  • MAC Lung Disease chevron_right
    • close
    CMEducation Resources iQ&A
    • person
    • Program Home
    • Access All Programs
    • Specialtieschevron_right
      • chevron_leftTopics
      • Biologics
      • Cancer
      • Cardiology
      • Dermatology
      • Diabetes
      • Hypothyroidism
      • MAC Lung Disease
      • Neurology
      • Primary Care
    • Submit A Question
    close

    Claire Zar-Kessler, MD

    Claire Zar-Kessler, MD

    Medical Director, Pediatric Neurogastroenterology Program
    Instructor, Harvard Medical School
    Mass General Hospital for Children
    Boston, MA


    Related Videos

    Other than ERT and chaperone therapy, what other pharmacologic interventions are effective and safe for treating the GI symptoms of FD? Video

    Other than ERT and chaperone therapy, what other pharmacologic interventions are effective and safe for treating the GI symptoms of FD?

    Based on Registry Data for Fabry Disease, what have we learned about the importance of GI symptoms—including gender-based differences—in the context of improving awareness of FD as a condition for which we should screen? Video

    Based on Registry Data for Fabry Disease, what have we learned about the importance of GI symptoms—including gender-based differences—in the context of improving awareness of FD as a condition for which we should screen?

    Can you focus on the earliest age group in which GI symptoms of FD can plausibly be detected? Video

    Can you focus on the earliest age group in which GI symptoms of FD can plausibly be detected?

    Can you discuss a specific adult patient who came to you with GI symptoms and confirmed Fabry Disease, in whom therapeutic intervention improved their GI manifestations and quality of life? Video

    Can you discuss a specific adult patient who came to you with GI symptoms and confirmed Fabry Disease, in whom therapeutic intervention improved their GI manifestations and quality of life?

    At what age can FD-consistent GI manifestations first emerge? What is the most frequent misdiagnosis of GI symptoms that, in retrospect, were the first signs of FD in an individual patient? Video

    At what age can FD-consistent GI manifestations first emerge? What is the most frequent misdiagnosis of GI symptoms that, in retrospect, were the first signs of FD in an individual patient?

    Since a heterogeneous range of GI symptomatology is associated with Fabry Disease, can you discuss the spectrum of symptoms that are encountered? Video

    Since a heterogeneous range of GI symptomatology is associated with Fabry Disease, can you discuss the spectrum of symptoms that are encountered?

    How often are GI symptoms the portal for entertaining and confirming the diagnosis of FD? Video

    How often are GI symptoms the portal for entertaining and confirming the diagnosis of FD?

    How does deficiency of the lysosomal enzyme, alpha-galactosidase A lead to GI symptoms? What is the GI-related pathobiology of Fabry Disease? Through what vascular, tissue, and neuropaths mechanisms does GL-3 accumulation cause GI symptoms? Video

    How does deficiency of the lysosomal enzyme, alpha-galactosidase A lead to GI symptoms? What is the GI-related pathobiology of Fabry Disease? Through what vascular, tissue, and neuropaths mechanisms does GL-3 accumulation cause GI symptoms?

    What are the specific GI symptoms encountered in patients with FD? And what specific symptom patterns should alert the clinician that FD should be excluded in the differential diagnosis? Video

    What are the specific GI symptoms encountered in patients with FD? And what specific symptom patterns should alert the clinician that FD should be excluded in the differential diagnosis?

    Disclaimer:
    Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
    Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
    Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
    Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

    Clinical Webcasts®

    Powered by BroadcastMedBROADCASTMED